Trinity Biotech (TRIB) Asset Utilization Ratio (2009 - 2024)

Trinity Biotech (TRIB) has reported Asset Utilization Ratio for 16 consecutive years, with 0.61 the latest figure, recorded in Q4 2024.

• Quarterly Asset Utilization Ratio fell 33.61% year-over-year to 0.61 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.61 (down 33.61% YoY) and the FY2025 annual result came in at 0.42, down 44.47% from the prior year.
• Asset Utilization Ratio declined to 0.61 in Q4 2024 per TRIB's latest filing, from 0.62 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for TRIB reached as high as 0.92 in Q4 2023 and fell as low as 0.61 in Q4 2024.
• A 5-year average of 0.73 and a median of 0.71 in 2023 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 40.38% — and 2024, when it slumped 33.61%.
• Year by year, Asset Utilization Ratio stood at 0.77 in 2020, then climbed by 0.51% to 0.77 in 2021, then declined by 14.46% to 0.66 in 2022, then jumped by 40.38% to 0.92 in 2023, then sank by 33.61% to 0.61 in 2024.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.61, 0.62, and 0.64 for Q4 2024, Q3 2024, and Q2 2024 respectively.